IQGAP3 and urinary bladder cancer: In a cohort of 355 patients with either bladder cancer or non-malignant hematuria, IQGAP3/BMP4 and IQGAP3/FAM107A urine PCR ratios yielded a sensitivity of 71.0%, specificity of 88.6%, and AUC of 0.862 [99].